Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Risk for COVID-19-related death up in association with male sex, older age, preexisting comorbidities, insulin use
Read More »Risk Factors ID’d for COVID-19-Related Death in Diabetes
Farxiga Approved to Reduce Risk for CKD Progression
SGLT2 inhibitor approved for patients with CKD to prevent kidney function decline, kidney failure, CV death, hospitalization for heart failure
Read More »FDA Poised to Ban Menthol Cigarettes
Agency said it will also seek to ban menthol and other flavors in mass-produced cigars
Read More »Younger Age at T2DM Onset Linked to Subsequent Dementia Risk
Every five-year younger age at onset of type 2 diabetes linked to hazard ratio of dementia of 1.24 at age 70 years
Read More »White House to Propose Menthol Cigarette Ban
Also anticipated is a ban on menthol and other flavors in mass-produced cigars, including small cigars
Read More »Hearing Loss Tied to Less Physical Activity in Older Adults
Mild and moderate-or-greater hearing is equivalent to 5.84 and 7.28 years of aging, respectively
Read More »Once-Weekly Insulin Icodec Promising for Type 2 Diabetes
Icodec results in greater increase in time-in-range versus once-daily insulin glargine U100 in two phase 2 randomized, open-label trials
Read More »Gender, Race Affects Access to SGLT2-Inhibitor Therapy for T2DM
Women, Black or Asian patients less likely to receive sodium-glucose cotransporter 2 inhibitor treatment for type 2 diabetes
Read More »Gender-Affirming Hormone Therapy Tied to Systolic BP Changes
Within two to four months, increases, decreases in systolic BP seen in transmasculine, transfeminine adults, respectively
Read More »Biden Administration Lifts Restrictions on Medical Research Using Fetal Tissues
All projects that had been approved before the Trump administration restrictions 'will be reinstated without further review'
Read More »